Nipple Aspirate Fluid: A Non-Invasive Method to Identify Breast Cancer Risk
Author Information
Author(s): ER Sauter, E Ross, M Daly, A Klein-Szanto, PF Engstrom, A Sorling, J Malick, H Ehya
Primary Institution: Fox Chase Cancer Center
Hypothesis
Higher levels of cellular markers in nipple aspirate fluid correlate with increasing breast cancer risk.
Conclusion
Nipple aspirate fluid can be reliably obtained and may serve as a useful tool for identifying breast cancer risk through cellular markers.
Supporting Evidence
- NAF was obtained in 167 out of 177 subjects, showing a high success rate.
- NAF cytology correlated with increased breast cancer risk with a p-value of 0.002.
- Specimens were sufficiently cellular for analysis in 96% of cases.
Takeaway
Doctors can collect fluid from a woman's nipple to check for signs of breast cancer without needing surgery, which is quick and easy.
Methodology
Nipple aspirate fluid was collected from 177 subjects using a modified breast pump to evaluate cellular biomarkers.
Potential Biases
Potential bias due to the exclusion of certain demographics and reliance on self-reported data.
Limitations
The ability to obtain nipple aspirate fluid was limited in some subjects, and the study did not include women under 30 or over 65 years old.
Participant Demographics
Non-Asian women aged 30-65 years, with varying breast cancer risk factors.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website